MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$5,486K
Net Income
-$32,097K
Net Profit Margin
-585.07%
EPS
-$1.02
Unit: Thousand (K) dollars
Revenue Breakdown
    • License
    • Product

Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
5,486 1,901 -7,162* 12,500
Cost of sales
280 1,076 105* -
Selling, general and administrative
39,378 44,960 30,864* 27,596
Research and development
0 0 -608* 3,791
Total operating expenses
39,658 46,036 30,360* 31,387
Loss from operations
-34,172 -44,135 -37,522* -18,887
Other (expense) income
-13 3 -520* -14
Interest income
2,270 2,644 3,086* 2,201
Total other income, net
2,257 2,647 2,565* 2,187
Net loss before income taxes
-31,915 --34,957* -16,700
Income tax expense
3 --248* 0
Net loss
-31,918 -41,488 -34,709* -16,700
Unrealized gain on marketable securities
-179 -692 -110* 189
Comprehensive loss
-32,097 -42,180 -34,819 -16,511
Basic EPS
-1.02 -1.32 -1.168 -0.59
Diluted EPS
-1.02 -1.32 -1.168 -0.59
Basic Average Shares
31,374,311 31,352,702 29,819,902 28,540,519
Diluted Average Shares
31,374,311 31,352,702 29,819,902 28,540,519
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$32,097K (-114.02%↓ Y/Y)Net loss-$31,918K (-114.04%↓ Y/Y)Unrealized gain onmarketable securities-$179K (-110.59%↓ Y/Y)Interest income$2,270K (1.07%↑ Y/Y)Net loss beforeincome taxes-$31,915K (-121.45%↓ Y/Y)Income tax expense$3K (-99.40%↓ Y/Y)Total other income,net$2,257K (-7.69%↓ Y/Y)License$3,750K Product$1,736K Other (expense)income-$13K (-106.53%↓ Y/Y)Loss from operations-$34,172K (-102.72%↓ Y/Y)Total revenue$5,486K (9.72%↑ Y/Y)Total operatingexpenses$39,658K (81.44%↑ Y/Y)Selling, general andadministrative$39,378K (207.74%↑ Y/Y)Cost of sales$280K

LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics, Inc. (LENZ)